Ceftaroline in complicated skin and skin-structure infections

Vista sencilla de ítem
dc.contributor.authorHernandez, Paul O.
dc.contributor.authorTyring, Stephen
dc.contributor.authorLema, Sergio
dc.contributor.authorMendoza, Natalia
dc.date.accessioned2020-05-12T22:27:59Z
dc.date.available2020-05-12T22:27:59Z
dc.date.issued2012
dc.description.abstractenglishCeftaroline is an advanced-generation cephalosporin antibiotic recently approved by the US Food and Drug Administration for the treatment of complicated skin and skin-structure infections (cSSSIs). This intravenous broad-spectrum antibiotic exerts potent bactericidal activity by inhibiting bacterial cell wall synthesis. A high affinity for the penicillin-binding protein 2a (PBP2a) of methicillin-resistant Staphylococcus aureus (MRSA) makes the drug especially beneficial to patients with MRSA cSSSIs. Ceftaroline has proved in multiple well-conducted clinical trials to have an excellent safety and efficacy profile. In adjusted doses it is also recommended for patients with renal or hepatic impairment. Furthermore, the clinical effectiveness and high cure rate demonstrated by ceftaroline in cSSSIs, including those caused by MRSA and other multidrug-resistant strains, warrants its consideration as a first-line treatment option for cSSSIs. This article reviews ceftaroline and its pharmacology, efficacy, and safety data to further elucidate its role in the treatment of cSSSIs.eng
dc.format.mimetypeapplication/pdf
dc.identifier.doihttps://dx.doi.org/10.2147%2FIDR.S17432
dc.identifier.issn1178-6973
dc.identifier.urihttps://hdl.handle.net/20.500.12495/2658
dc.language.isoeng
dc.publisherDove Medical Press Ltdspa
dc.publisher.journalInfection and Drug Resistancespa
dc.relation.ispartofseriesInfection and Drug Resistance, 1178-6973, Vol.5, 2012, p.23-35spa
dc.relation.urihttps://www.dovepress.com/ceftaroline-in-complicated-skin-and-skin-structure-infections-peer-reviewed-article-IDR
dc.rights.creativecommons2012
dc.rights.localAcceso cerradospa
dc.subject.decsStaphylococcus aureusspa
dc.subject.decsInsuficiencia renalspa
dc.subject.decsEnfermedades de la Pielspa
dc.subject.keywordsCeftarolinespa
dc.subject.keywordsCephalosporinspa
dc.subject.keywordsComplicated skin and skin-structure infectionsspa
dc.titleCeftaroline in complicated skin and skin-structure infectionsspa
dc.typearticlespa
dc.type.hasversioninfo:eu-repo/semantics/publishedVersion
dc.type.localartículospa

Archivos

Bloque original
Mostrando 1 - 1 de 1
No hay miniatura disponible
Nombre:
Hernandez P.O., Lema S., Tyring S.K., Mendoza N._2012.pdf
Tamaño:
224.77 KB
Formato:
Adobe Portable Document Format
Descripción:
Descargar
Bloque de licencias
Mostrando 1 - 1 de 1
No hay miniatura disponible
Nombre:
license.txt
Tamaño:
1.71 KB
Formato:
Item-specific license agreed upon to submission
Descripción:
Descargar

Colecciones

Artículos